CAPITATION

财团基金(75万美元)。财团资金部分用于在 研究基地以及北中癌症治疗小组成员站点没有自己的CCOP 格兰特。这笔资金是按照美国国立卫生研究院规定的费率提供的；目前每例信贷2,000美元， 仅限于癌症控制协议的CAMPATION报销。预测这一项目所需的总资金 赠款的组成部分取决于许多变量，如新协议上线、关闭 现有协议和参与地点的应计活动。请为这份提交申请提供资金 支持所有非CCOP NCCTG站点的375个应计项目，每个应计项目的当前费率为2,000美元，用于总请求 75万美元。

Consortium Funds ($750,000). The consortium funding component is utilized to provide reimbursement at the research base as well as at North Central Cancer Treatment Group member sites not having their own CCOP grant. This funding is provided at the rate specified by the NIH; currently $2,000 per case credit, and is restricted to capitation reimbursement for cancer control protocols. Predicting the total funding needed for this component of the grant is dependent on numerous variables such as new protocols coming on-line, closing of existing protocols, and the accrual activity of participating sites. Funding is requested for this submission to support 375 total accruals at all non-CCOP NCCTG sites at the current rate of $2,000 each, for a total request of $750,000.